Voorberg J - Search Results

1

Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg593-->Cys mutation using phage display.

Bril WS, Turenhout EA, Kaijen PH, van den Brink EN, Koopman MM, Peters M, Voorberg J. Bril WS, et al. Among authors: voorberg j. Br J Haematol. 2002 Nov;119(2):393-6. doi: 10.1046/j.1365-2141.2002.03856.x. Br J Haematol. 2002. PMID: 12406075 Free article.

2

Intracellular retention of a factor VIII protein with an Arg2307-->Gln mutation as a cause of haemophilia A.

Voorberg J, de Laaf RT, Koster PM, van Mourik JA. Voorberg J, et al. Biochem J. 1996 Sep 15;318 ( Pt 3)(Pt 3):931-7. doi: 10.1042/bj3180931. Biochem J. 1996. PMID: 8836140 Free PMC article.

3

The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.

Fijnvandraat K, Turenhout EA, van den Brink EN, ten Cate JW, van Mourik JA, Peters M, Voorberg J. Fijnvandraat K, et al. Among authors: voorberg j. Blood. 1997 Jun 15;89(12):4371-7. Blood. 1997. PMID: 9192760 Free article.

4

A human alloantibody interferes with binding of factor IXa to the factor VIII light chain.

Fijnvandraat K, Celie PH, Turenhout EA, ten Cate JW, van Mourik JA, Mertens K, Peters M, Voorberg J. Fijnvandraat K, et al. Among authors: voorberg j. Blood. 1998 Apr 1;91(7):2347-52. Blood. 1998. PMID: 9516133 Free article.

5

Small GTP-binding proteins in human endothelial cells.

de Leeuw HP, Koster PM, Calafat J, Janssen H, van Zonneveld AJ, van Mourik JA, Voorberg J. de Leeuw HP, et al. Among authors: voorberg j. Br J Haematol. 1998 Oct;103(1):15-9. doi: 10.1046/j.1365-2141.1998.00965.x. Br J Haematol. 1998. PMID: 9792283 Free article.

6

Longitudinal analysis of factor VIII inhibitors in a previously untreated mild haemophilia A patient with an Arg593-->Cys substitution.

van den Brink EN, Timmermans SM, Turenhout EA, Bank CM, Fijnvandraat K, Voorberg J, Peters M. van den Brink EN, et al. Among authors: voorberg j. Thromb Haemost. 1999 May;81(5):723-6. Thromb Haemost. 1999. PMID: 10365744

7

Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes.

van Den Brink EN, Turenhout EA, Davies J, Bovenschen N, Fijnvandraat K, Ouwehand WH, Peters M, Voorberg J. van Den Brink EN, et al. Among authors: voorberg j. Blood. 2000 Jan 15;95(2):558-63. Blood. 2000. PMID: 10627462 Free article.

8

Intracellular accumulation of factor VIII induced by missense mutations Arg593-->Cys and Asn618-->Ser explains cross-reacting material-reduced haemophilia A.

Roelse JC, De Laaf RT, Timmermans SM, Peters M, Van Mourik JA, Voorberg J. Roelse JC, et al. Among authors: voorberg j. Br J Haematol. 2000 Feb;108(2):241-6. doi: 10.1046/j.1365-2141.2000.01834.x. Br J Haematol. 2000. PMID: 10691849 Free article.

9

Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain.

van den Brink EN, Turenhout EA, Bank CM, Fijnvandraat K, Peters M, Voorberg J. van den Brink EN, et al. Among authors: voorberg j. Blood. 2000 Jul 15;96(2):540-5. Blood. 2000. PMID: 10887116 Free article.

10

Phage display technology: a tool to explore the diversity of inhibitors to blood coagulation factor VIII.

Voorberg J, van den Brink EN. Voorberg J, et al. Semin Thromb Hemost. 2000;26(2):143-50. doi: 10.1055/s-2000-9816. Semin Thromb Hemost. 2000. PMID: 10919406 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters